Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Next generation immunohistochemistry: Emerging substitutes to genetic testing?

Andrici J, Gill AJ, Hornick JL.

Semin Diagn Pathol. 2017 Jun 27. pii: S0740-2570(17)30064-3. doi: 10.1053/j.semdp.2017.05.004. [Epub ahead of print] Review.

PMID:
28662997
2.

Cabozantinib for the treatment of kidney cancer.

Abdelaziz A, Vaishampayan U.

Expert Rev Anticancer Ther. 2017 Jul;17(7):577-584. doi: 10.1080/14737140.2017.1344553. Review.

PMID:
28633552
3.

Imaging of Renal Medullary Carcinoma.

Greco F, Faiella E, Santucci D, Mallio CA, Nezzo M, Quattrocchi CC, Beomonte Zobel B, Grasso RF.

J Kidney Cancer VHL. 2017 Mar 21;4(1):1-7. doi: 10.15586/jkcvhl.2017.62. eCollection 2017. Review.

4.

[A Familial Non Medullary Thyroid Carcinoma (FNMTC) : a clinical and genetic update].

Valdes-Socin H, Palmeira L, Burlacu MC, Daly AF, Bours V, Beckers A.

Rev Med Liege. 2016 Dec;71(12):557-561. Review. French.

PMID:
28387096
5.

Clinicopathologic and Molecular Pathology of Collecting Duct Carcinoma and Related Renal Cell Carcinomas.

Seo AN, Yoon G, Ro JY.

Adv Anat Pathol. 2017 Mar;24(2):65-77. doi: 10.1097/PAP.0000000000000138. Review.

PMID:
28181950
6.

Clinical Pharmacokinetics and Pharmacodynamics of Cabozantinib.

Lacy SA, Miles DR, Nguyen LT.

Clin Pharmacokinet. 2017 May;56(5):477-491. doi: 10.1007/s40262-016-0461-9. Review.

PMID:
27734291
7.

Pediatric renal and genitourinary tract tumors and the contributions of Dr. Louis "Pepper" Dehner therewith.

Jarzembowski JA.

Semin Diagn Pathol. 2016 Nov;33(6):419-426. doi: 10.1053/j.semdp.2016.08.005. Epub 2016 Aug 31. Review.

PMID:
27720562
8.

Imaging Manifestations of Hematologic Diseases with Renal and Perinephric Involvement.

Purysko AS, Westphalen AC, Remer EM, Coppa CP, Leão Filho HM, Herts BR.

Radiographics. 2016 Jul-Aug;36(4):1038-54. doi: 10.1148/rg.2016150213. Epub 2016 Jun 3. Review.

PMID:
27257766
9.

Sorting the Alphabet Soup of Renal Pathology: A Review.

Curran-Melendez SM, Hartman MS, Heller MT, Okechukwu N.

Curr Probl Diagn Radiol. 2016 Jan 28. pii: S0363-0188(15)30049-9. doi: 10.1067/j.cpradiol.2016.01.003. [Epub ahead of print] Review.

PMID:
26928791
10.

Profile of nintedanib in the treatment of solid tumors: the evidence to date.

Awasthi N, Schwarz RE.

Onco Targets Ther. 2015 Dec 8;8:3691-701. doi: 10.2147/OTT.S78805. eCollection 2015. Review.

11.

Thyroid C-Cell Biology and Oncogenic Transformation.

Cote GJ, Grubbs EG, Hofmann MC.

Recent Results Cancer Res. 2015;204:1-39. doi: 10.1007/978-3-319-22542-5_1. Review.

PMID:
26494382
12.

Genitourinary manifestations of sickle cell disease.

Gebreselassie S, Simmons MN, Montague DK.

Cleve Clin J Med. 2015 Oct;82(10):679-83. doi: 10.3949/ccjm.82a.14029. Review.

13.

[Lymph node and distant metastases of thyroid gland cancer. Metastases in the thyroid glands].

Schmid KW.

Pathologe. 2015 Nov;36 Suppl 2:171-5. doi: 10.1007/s00292-015-0071-6. Review. German.

PMID:
26357953
14.

Adverse Effects Associated With Newer Diabetes Therapies.

Akiyode OF, Adesoye AA.

J Pharm Pract. 2017 Apr;30(2):238-244. doi: 10.1177/0897190015594732. Epub 2016 Jul 9. Review.

PMID:
26169212
15.

Cabozantinib in Thyroid Cancer.

Fallahi P, Ferrari SM, Di Bari F, Materazzi G, Benvenga S, Miccoli P, Antonelli A.

Recent Pat Anticancer Drug Discov. 2015;10(3):259-69. Review.

PMID:
26152149
16.

Aggressive thyroid cancer: targeted therapy with sorafenib.

Corrado A, Ferrari SM, Politti U, Mazzi V, Miccoli M, Materazzi G, Antonelli A, Ulisse S, Fallahi P, Miccoli P.

Minerva Endocrinol. 2017 Mar;42(1):64-76. doi: 10.23736/S0391-1977.16.02229-X. Epub 2015 Jun 26. Review.

PMID:
26112458
17.

Renal medullary carcinoma and sickle cell trait: A systematic review.

Alvarez O, Rodriguez MM, Jordan L, Sarnaik S.

Pediatr Blood Cancer. 2015 Oct;62(10):1694-9. doi: 10.1002/pbc.25592. Epub 2015 Jun 5. Review.

PMID:
26053587
18.

Review of renal cell carcinoma with rhabdoid features with focus on clinical and pathobiological aspects.

Kuroda N, Karashima T, Inoue K, Kasajima A, Ohe C, Kawakami F, Mikami S, Matsuura K, Moriyama M, Nagashima Y, Petersson F, Lopez JI, Cohen RJ, Michal M, Hes O.

Pol J Pathol. 2015 Mar;66(1):3-8. Review.

19.

Diagnostic approach to hereditary renal cell carcinoma.

Gupta S, Kang HC, Ganeshan DM, Bathala TK, Kundra V.

AJR Am J Roentgenol. 2015 May;204(5):1031-41. doi: 10.2214/AJR.14.13514. Review.

PMID:
25905938
20.

Eph/ephrin signaling in the kidney and lower urinary tract.

Weiss AC, Kispert A.

Pediatr Nephrol. 2016 Mar;31(3):359-71. doi: 10.1007/s00467-015-3112-8. Epub 2015 Apr 23. Review.

PMID:
25903642

Supplemental Content

Loading ...
Support Center